Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts Top 3 Medical Device ETFs for Investors in 2026 January 15, 2026 Silver Price Surges Past US$90 to Hit New All-time High January 15, 2026 Lithium Prices Reach Two-Year Highs as Rally Continues January 15, 2026